These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
431 related items for PubMed ID: 15889354
1. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Musher DM, Aslam S, Logan N, Nallacheru S, Bhaila I, Borchert F, Hamill RJ. Clin Infect Dis; 2005 Jun 01; 40(11):1586-90. PubMed ID: 15889354 [Abstract] [Full Text] [Related]
4. The clinical spectrum of Clostridium difficile colitis in immunocompromised patients. Schweitzer MA, Sweiss I, Silver DL, Stellato TA. Am Surg; 1996 Jul 01; 62(7):603-7; discussion 607-8. PubMed ID: 8651560 [Abstract] [Full Text] [Related]
5. Update on Clostridium difficile-induced colitis, Part 2. Reinke CM, Messick CR. Am J Hosp Pharm; 1994 Aug 01; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924 [Abstract] [Full Text] [Related]
6. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Pépin J, Valiquette L, Gagnon S, Routhier S, Brazeau I. Am J Gastroenterol; 2007 Dec 01; 102(12):2781-8. PubMed ID: 17900327 [Abstract] [Full Text] [Related]
8. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, Godin D, Bourassa C. Clin Infect Dis; 2005 Jun 01; 40(11):1591-7. PubMed ID: 15889355 [Abstract] [Full Text] [Related]
9. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. Clin Infect Dis; 2007 Aug 01; 45(3):302-7. PubMed ID: 17599306 [Abstract] [Full Text] [Related]
11. Past, present, and future therapies for Clostridium difficile-associated disease. Surowiec D, Kuyumjian AG, Wynd MA, Cicogna CE. Ann Pharmacother; 2006 Dec 01; 40(12):2155-63. PubMed ID: 17148650 [Abstract] [Full Text] [Related]
12. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting. Venugopal AA, Riederer K, Patel SM, Szpunar S, Jahamy H, Valenti S, Shemes SP, Khatib R, Johnson LB. Scand J Infect Dis; 2012 Apr 01; 44(4):243-9. PubMed ID: 22077148 [Abstract] [Full Text] [Related]
13. [Relapsing infections with Clostridium difficile]. Visser WE, Dingemans-Dumas AM, Bac DJ. Ned Tijdschr Geneeskd; 2005 Oct 22; 149(43):2381-5. PubMed ID: 16277125 [Abstract] [Full Text] [Related]
14. Treatment of Clostridium difficile-associated disease. Leffler DA, Lamont JT. Gastroenterology; 2009 May 22; 136(6):1899-912. PubMed ID: 19457418 [Abstract] [Full Text] [Related]
15. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies. Parmar SR, Bhatt V, Yang J, Zhang Q, Schuster M. J Oncol Pharm Pract; 2014 Jun 22; 20(3):172-82. PubMed ID: 23804627 [Abstract] [Full Text] [Related]
16. Metronidazole: an alternate therapy for antibiotic-associated colitis. Cherry RD, Portnoy D, Jabbari M, Daly DS, Kinnear DG, Goresky CA. Gastroenterology; 1982 May 22; 82(5 Pt 1):849-51. PubMed ID: 7060906 [Abstract] [Full Text] [Related]